Authors
Latest:
Specialty Pharmacy: Not for the Faint of Heart“You can put yourself out of business by getting into the specialty pharmacy business.â€
Latest:
A Review of DupilumabDupixent is the first FDA-approved medicine for adults with chronic rhinosinusitis with nasal polyposis and the only approved therapy shown to shrink nasal polyp size and improve the signs and symptoms of the associated chronic rhinosinusitis.
Latest:
Value-Based Care Is Becoming Real: Are You Prepared?Through value-based care initiatives, payers are increasingly holding both providers and pharmaceutical manufacturers accountable for choosing the right combination of drug regimens and treatment protocols.
Latest:
Hybrid Models Can Transform Team ChemistryMorristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
Review of Outcomes Associated With Formulary Restrictions: Focus on Step TherapyAs healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Latest:
Going Above and Beyond as PharmacistsLearn more about what it's like to work for a Walgreens specialty pharmacy.
Latest:
Oncology Drug Management: Technology SolutionsCardinal Health has expanded its services with an end-to-end solution for specialty oncology drug management covered under the medical and pharmacy benefits.
Latest:
Concerns Persist about the 340B ProgramCreated in 1992 as part of the Veterans Health Care Act, the 340B drug pricing program requires drug companies to provide discounts sometimes as much as 50% to covered entities, hospitals, and clinics that treat low-income and uninsured patients.
Latest:
High Carbohydrate Diet May Increase Mortality Risk in Certain CancersThe findings suggest that a patient’s diet may impact their ability to combat head and neck cancer.
Latest:
Pediatric Asthma Treatment Prescribing Needs ImprovementPrescribed dosage of aminophylline in children with acute severe asthma may not improve the condition.
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer DeviceThere is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.
Latest:
Lung Cancer: Copayments and Behavior Following Erlotinib Formulary Tier ChangeMoving erlotinib from formulary tier 3 to tier 2 resulted in lower copayments and higher treatment persistence among lung cancer patients.
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric HospitalAdherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Latest:
Novel Therapies in Atopic DermatitisAtopic dermatitis (AD) is among the most common chronic inflammatory skin disorders in the Western world, with studies suggesting that 10.7% of the US population is affected.
Latest:
Probiotics for Prevention: Can You 'C' a DIFFerence?Probiotics may offer a potential treatment for clostridium difficile infection.
Latest:
Evidence-Based Adherence Classes for Combination Antihypertensive, Lipid-Lowering, and Antidiabetic TherapyAdherence classes were determined for patients taking multiple medications (ie, lipid-lowering, antihypertensive, antidiabetic) and were found to be related to serum profiles and risk of adverse events.
Latest:
Medication Management: Measuring What MattersAs new care delivery models evolve to focus on value, accountability, and team-based care, new measure development opportunities exist to address care gaps and to support team-based care delivery systems and care transitions.
